Nasomet Nasal 50MCG

100411200400101

Nasomet Nasal 50MCG

250.00৳ 

Stock Status:

In Stock

  • *Upload Prescription

    • (max file size 80 MB)

Description

Indications

Mometasone Furoate Nasal Spray is used to treat the nasal symptoms of seasonal and perennial allergic rhinitis in adults and children aged 2 years and older. It is approved for the prevention of nasal symptoms of seasonal allergic rhinitis in adults and adolescents aged 12 and up. It is also approved for the treatment of nasal polyps in individuals aged 18 and up.

Pharmacology

Mometasone Furoate Monohydrate is a corticosteroid with anti-inflammatory effects. The specific mechanism of action of corticosteroids on allergic rhinitis is unknown. Corticosteroids have been found to have a wide variety of effects on numerous cell types (e.g., mast cells, eosinophils, neutrophils, macrophages, and lymphocytes) and mediators of inflammation (e.g., histamines, eicosanoids, leukotrienes, and cytokines). In the concentration range of 5 to 500 ng/mL, protein binding for Mometasone Furoate was found to be 98 to 99 percent. Mometasone Furoate has an effective plasma elimination half-life of 5.8 hours.

Dosage

Allergic Rhinitis-

  • Adults and Children 12 Years of Age and Older: The recommended dose for prophylaxis and treatment of the nasal symptoms of seasonal allergic rhinitis and treatment of nasal symptoms of perennial allergic rhinitis is two sprays (50 mcg of Mometasone Furoate in each spray) in each nostril once daily (total daily dose of 100 mcg). In patients with a known seasonal allergen that precipitates nasal symptoms of seasonal allergic rhinitis, prophylaxis with Mometasone Nasal Spray, 50 mcg (200 mcg/day) is recommended 2 to 4 weeks prior to the anticipated start of the pollen season.
  • Children 2 to 11 Years of Age: The recommended dose for treatment of the nasal symptoms of seasonal and perennial allergic rhinitis is one spray (50 mcg of Mometasone Furoate in each spray) in each nostril once daily (total daily dose of 100 mcg).

Nasal Polyps Adults-

  • 18 years of Age and Older: The recommended dose for nasal polyps is two sprays (50 mcg of Mometasone Furoate in each spray) in each nostril twice daily (total daily dose of 400 mcg). A dose of two sprays (50 mcg of mometasone furoate in each spray) in each nostril once daily (total daily dose of 200 mcg) is also effective in some patients.

Administration

How to use the Nasal Spray-

  • Shake the bottle gently and remove the dust cover.
  • Hold the spray with your forefinger and middle finger on either side of the nozzle and your thumb underneath the bottle. Press down until a fine spray appears. If using it for the first time or if you have not used it for a week or more, press the nasal applicator several times until a fine moist comes out from the container.
  • Gently blow the nose to clear the nostrils.
  • Close one nostril and carefully insert the nasal applicator into the open nostril. Tilt your head forward slightly and keep the spray upright. Breathe in through your nose and while breathing in, press the white collar of the nasal applicator firmly down once to release a spray.
  • Breathe out through your mouth.
  • Repeat the above steps in the same/another nostril for consecutive doses.

Cleaning: The nasal spray should be cleaned at least once a week. The procedures are as follows-

  • Remove the dust cover.
  • Gently pull off the nasal applicator.
  • Wash the applicator and dust cover in warm water.
  • Shake off the excess water and leave it to dry in a normal place. Avoid applying additional heat.
  • Gently push the applicator back on the top of the bottle and re-fix the dust cover.

Interaction

There are no drug interactions of note with Mometasone Furoate.

Contraindications

Any hypersensitivity to any of the components in this formulation precludes its usage.

Side Effects

The most common side effects were headache, viral infection, sore throat, nosebleeds, and coughing.

Pregnancy & Lactation

Pregnancy; There are no adequate and well-controlled studies on pregnant women. Mometasone Furoate, like other corticosteroids, should be used during pregnancy only if the potential benefits justify the potential risk to the fetus.

Lactation; It is not known lf Mometasone Furoate is excreted in human milk. Since other corticosteroids are excreted in human milk, caution should be used when Mometasone Furoate is administered to nursing women.

Precautions & Warnings

Use with caution in active or inactive tuberculosis infection, herpes simplex virus infection of the eye, untreated infections affecting the body as a whole, etc.

Therapeutic Class

Preparations for Nasal Steroids

Storage Conditions

Keep below 30°C and away from light and moisture. Keep out of children’s reach.

Generic

Mometasone Furoate

Pharmaceutical Name

Beximco Pharmaceuticals Ltd.